Core Insights - The stock of Kefu Medical (301087) closed at 42.78 yuan on November 19, 2025, with a slight increase of 0.12% and a trading volume of 11,500 hands, resulting in a transaction value of 49.04 million yuan [1][2]. Financial Performance - For the first three quarters of 2025, Kefu Medical reported a main revenue of 2.398 billion yuan, a year-on-year increase of 6.63%, and a net profit attributable to shareholders of 260 million yuan, up 3.3% year-on-year [3]. - In Q3 2025, the company achieved a single-quarter main revenue of 902 million yuan, reflecting a significant year-on-year increase of 30.72%, and a net profit of approximately 92.83 million yuan, up 38.68% year-on-year [3]. - The company's gross profit margin stands at 53.35%, with a net profit margin of 10.82% [3]. Market Position - Kefu Medical's total market capitalization is 8.937 billion yuan, ranking 42nd in the medical device industry, while its net assets amount to 4.75 billion yuan, ranking 29th [3]. - The company has a price-to-earnings ratio (P/E) of 25.76, significantly lower than the industry average of 56.7, placing it 23rd in the industry [3]. Investment Sentiment - Over the past 90 days, 9 institutions have rated Kefu Medical with a "buy" recommendation, and the average target price set by these institutions is 53.84 yuan [4].
股票行情快报：可孚医疗（301087）11月19日主力资金净卖出283.95万元